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Abstract
Background: Uptake rates for Down syndrome screening in the Netherlands are low compared to other European
countries. To investigate the low uptake, we explored women’s reasons for participation and possible influences
of national healthcare system characteristics. Dutch prenatal care is characterised by an approach aimed at a low
degree of medicalisation, with pregnant women initially considered to be at low risk. Prenatal screening for Down
syndrome is offered to all women, with a ‘right not to know’ for women who do not want to be informed on this
screening. At the time this study was performed, the test was not reimbursed for women aged 35 and younger.
Methods: We conducted a qualitative study to explore reasons for participation and possible influences of
healthcare system characteristics. Data were collected via ten semi-structured focus groups with women
declining or accepting the offer of Down syndrome screening (n = 46). All focus groups were audio- and
videotaped, transcribed verbatim, coded and content analysed.
Results: Women declining Down syndrome screening did not consider Down syndrome a condition severe
enough to justify termination of pregnancy. Young women declining felt supported in their decision by perceived
confirmation of their obstetric caregiver and reassured by system characteristics (costs and age restriction). Women
accepting Down syndrome screening mainly wanted to be reassured or be prepared to care for a child with
Down syndrome. By weighing up the pros and cons of testing, obstetric caregivers supported young women who
accepted in the decision-making process. This was helpful, although some felt the need to defend their decision to
accept the test offer due to their young age. For some young women accepting testing, costs were considered a
disincentive to participate.
Conclusions: Presentation of prenatal screening affects how the offer is attended to, perceived and utilised. By
offering screening with age restriction and additional costs, declining is considered the preferred choice, which
might account for low Dutch uptake rates. Autonomous and informed decision-making in Down syndrome
screening should be based on the personal interest in knowing the individual risk of having a child with Down
syndrome and system characteristics should not influence participation.
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Background
In the Netherlands, obstetric care is characterised by an
approach aimed at a low degree of medicalisation. Preg-
nant women are initially considered to be at low risk,
and most women start their pregnancy with a primary
care midwife. As a consequence, most women receive
information on Down syndrome screening (DSS) from
their midwife, which is called prenatal counselling. Preg-
nant women receive prenatal counselling during their
first visit (around 8 weeks of gestation), after which they
make their decision about participation in DSS. The
offer to opt for DSS is presented in a way that helps pro-
spective mothers make a well-informed and autonomous
choice. In addition, specific training to provide correct
information for DSS to pregnant women is required for
obstetric caregivers prior to information provision [1].
During the study period (2012–2013), for women aged
36 and over, the test was free of charge, whereas for
younger women an additional fee was requested.
First trimester Down syndrome screening is performed
by maternal serum screening and by ultrasound mea-
surement of the foetal nuchal translucency in the first
trimester of pregnancy, between 9 and 14 weeks of
gestation [1]. Down syndrome is the most common
chromosomal aneuploidy (trisomy of chromosome 21)
with an incidence of about 1 in 700 live births. Down
syndrome is associated with intellectual disability, de-
layed development and certain physical characteristics.
Since 2007 DSS in the Netherlands is offered to all preg-
nant women. The offer is presented with a possibility of
‘the right not to know’ for women who do not want to
be informed about DSS [1]. The aim of DSS is to inform
prospective parents on the risk of Down syndrome (DS),
to provide them with timely options, including invasive
diagnostic procedures in the case of increased risk for
DS, and if diagnosed, preparation to care for a disabled
child or termination of pregnancy (TOP) [1]. In the
Netherlands, the overall uptake1 for DSS is low (<30 %)
when compared to other north-western European coun-
tries (74 % in England, 84 % in France and ≥90 % in
Denmark) [2–4]. In previous studies, it was suggested
that uptake rates are related to the approach adopted by
the system in which it is executed. In the Netherlands
for example, van den Berg et al. suggested that the low
uptake was related to the non-medicalised approach of
pregnancy [5]. In contrast, in France high uptake of
screening was associated with the tradition of a medica-
lised approach of pregnancy [6]. The way screening is
offered to pregnant women might be impacted by public
policies and the health systems in which they function.
As suggested in one of our earlier studies and by Bakker
et al., the unique characteristics of the Dutch screening
programme, such as a financial threshold, and ‘the right
not to be informed’ for younger women, might well ac-
count for the low uptake rates [7, 8]. To ensure uniform
information, it is mandatory for Dutch obstetric care-
givers to follow a specialised training on DSS counsel-
ling. The ‘right not to know’ is based on the ethical
principle of autonomy, giving patients the right to refuse
medical information and women are explicitly asked if
they want information on DSS, before information is
provided. Routinely offering DSS explicitly is not the
aim of the Dutch screening programme [8]. Based on
observations of information provision, Vassy et al. [6]
concluded that these characteristics contributed to equal
accessibility to the test without any encouragement to
accept it. Therefore there are some indications that
healthcare systems factors seem to influence the fre-
quency of utilisation. For example, utilisation of prenatal
diagnosis is sensitive to monetary incentives [9] and pro-
viding screening during a routine visit results in higher
uptake rates as compared to screening offered during a
separate visit [10].
While the influence of psychosocial, socio-cultural and
individual factors on utilisation of DSS [5, 7, 11–13]
(such as beliefs and attitudes towards disability and
TOP, religious denomination and ethnic background)
have been studied extensively, little is known about the
influence of national policies (healthcare system factors)
on individual decision-making. To gain a better under-
standing of the utilisation of DSS, the influence of the
external environment (healthcare system and public po-
licy) on individual decision making should be acknowl-
edged [14]. Therefore it is the aim of this study to
determine whether the specific Dutch screening policy
and healthcare system influence individual decision-
making and to investigate if these factors may explain
the low DSS uptake rates in the Netherlands. We there-
fore explored which factors impeded or facilitated the
use of DSS, and if and how system characteristics played
a role in these considerations.
Methods
One of the most frequently used frameworks for analy-
sing utilisation of healthcare services is the behavioural
model designed by Andersen (The Behavioral Model of
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Health Services Use, Fig. 1) [14]. We used the model to
understand utilisation of DSS and its interaction with
healthcare system characteristics. The model consists of
three groups of factors: predisposing factors (such as
health beliefs), need factors (objective and/or perceived
health/risk) and enabling factors (e.g. availability and ac-
cessibility), thus covering factors at both individual and
health system level, as well as their mutual interaction.
Moreover, it evaluates the influence of all these factors
on subsequent healthcare.
To address the research questions, a focus group ap-
proach and qualitative analysis were used.
Recruitment and sample characteristics
Pregnant women were recruited from four primary care
practices and from the primary care practice residing in
the University Medical Center of Utrecht. Because we
anticipated on differences between women that had
already received oral information on DSS and women
who had not, we used separate recruitment strategies.
Women were approached by their community midwife
either before their first visit (defined as pre-counselling)
or after their first visit (defined as post-counselling). In-
clusion criteria for participation included maternal age
18 or over, good understanding of the Dutch language,
and singleton pregnancy (if known). Women with a his-
tory of foetal anomalies, a current pregnancy with foetal
anomalies, maternal complications (a pregnancy identi-
fied at risk, according to national guidelines (List of
Obstetric Complications, the so-called Verloskundige
Indicatie Lijst)) or whose pregnancy was conceived by
assisted reproductive technology were excluded. To
prevent test experience bias, only participants who had
not yet received results of DSS or a foetal anomaly scan
were included.
Due to a relatively small period in which we were able
to include pregnant women and individual availability,
recruitment was a challenge. Over 350 women were
approached, of whom 46 participated in the focus
groups. The main reasons for non-participation were
unsuitable date/time, miscarriage, language barrier, or
because they already had had the test results or a foetal
anomaly scan at the date of the session.
Women were given information orally, and those in-
terested gave consent to be contacted by the researcher
with details about the study. Study personnel recruited
participants by phone and gave detailed information
about the study. Women who expressed interest in par-
ticipating in the study received written information,
gave schedule opportunities, provided contact details
and were assigned to a focus group based on their
screening preferences.
Data collection
As we were interested in which factors impeded or faci-
litated the use of DSS, women were assigned to specific
focus groups stratified according to their intention to
utilise DSS (to accept DSS, to decline DSS or in doubt
regarding participation). In practice, most women in our
study had already made their decision before attending
the focus groups, some even had taken the test already
(blood test only), but no one had received their test
result yet. As discussions could comprise ethical, emo-
tional and social dilemmas, homogeneous groups were
set up to create a safe and open environment in which
participants would feel free to express their feelings to
members of a uniform group [15, 16]. To capture the
initial decision making process, four focus groups con-
sisted of women who had not visited a healthcare profes-
sional yet (defined as pre counselling groups), of which
two focus groups consisted of women who were consi-
dering accepting the test (pre-accept group), and two
focus groups consisted of women who were considering
declining the test (pre-decline group). For a closer
analysis of the impact that professional advice had on
the decision-making process, six focus groups were
comprised of women who had already visited a
healthcare professional (defined as post-counselling
Fig. 1 The Behavioral Model of Health Services Use
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groups), of which three groups consisted of women
accepting the test (post-accept group), and three focus
groups consisted of women declining the test (post-
decline group) (Fig. 2).
We intended to conduct 14 focus groups (Fig. 2), but
while recruiting participants we observed that very few
women were in doubt and that those who were, already
had decided on DSS or otherwise before counselling.
Therefore we were unable to conduct any ‘in doubt’
groups. During post-counselling groups, we noticed that
the factors mentioned were very diverse and therefore
increased the number of ‘accept’ and ‘decline’ groups to
three each. In the pre-counselling group we did not ex-
perience this explicit diversity and therefore kept to the
original plan. In total we performed 10 focus groups
with 46 female participants (Fig. 2).
Informed consent was obtained from all participants
before the start of the focus group. Before the session,
all participants were asked to complete a brief question-
naire to collect information on demographics and a per-
sonal history.
All focus groups were performed with a moderator
guide. At each session a moderator was present to guide
the discussion and a minutes secretary to take notes.
The sessions started with the following question: “Have
you thought about participating in prenatal screening for
Down syndrome, why or why not?”, leading to a discus-
sion guided by the moderator. Subsequent questions
were used to clarify and probe for more depth guided by
the Andersen model. The model was not used to intro-
duce new arguments, but for an in-depth explanation of
arguments mentioned. For example, costs were men-
tioned in all groups, but only superficially. The moder-
ator would then ask if this argument played a role in the
decision-making process and how this affected their
ultimate decision. During the focus group sessions, the
moderator and secretary took notes of implicit observa-
tions (such as group interaction, emotions, and atmos-
phere) and compared and discussed these afterwards.
Focus group sessions lasted approximately 180 min,
were digitally recorded (audio and video) and tran-
scribed verbatim.
Analysis
Content analyses were performed using the qualitative
software programme Nvivo. Whole group analysis as de-
scribed by Spencer et al. were used to identify patterns
and major themes in the focus group transcripts. The
Fig. 2 Focus group set up. Intention and conducted. Grey arrows indicate comparison of groups. Focus groups with women intending to accept
versus focus groups with women intending to decline. Focus groups with women intending to accept pre-counselling versus focus groups with
women intending to accept post-counselling. Focus groups with women intending to decline pre-counselling versus focus groups with women
intending to decline post-counselling
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data produced by the groups were used as a whole, and
comparisons were made between them (Fig. 2) [17].
Participant-based group analysis was used to deepen the
theme of ambivalence, in which the contributions of the
participants were analysed separately within the context
of the group discussion [17].
The focus group transcripts were systematically coded.
First, we conducted open coding, in which we assigned
initial codes to text fragments. Two researchers with a
background in qualitative research (NC and TM) con-
ducted independent analysis of the transcript to reach
an understanding on the assigned open codes (subcat-
egories). As a measure of the level of influence, all focus
group transcripts were studied at the level of most fre-
quently mentioned subcategories. Subcategories coded
more than eight times or mentioned in at least four
focus groups (accept or decline focus groups) were stud-
ied for further analysis (axial coding). Then, the initial
codes were combined by making connections between
categories and placing them in a broader context related
to the research subject (Fig. 3a, b, c). To improve the
quality of the analysis, at various moments interim ana-
lyses were discussed among co-authors (JB and HB) with
a background in psychology and qualitative analysis.
Coding themes, for example, ‘risk awareness’ and ‘age-re-
lated risk’ both became subcategories of ‘risk perception’
(Fig. 3c). Finally, the ‘selective coding’ main categories
were, when possible, systematically related to categories
of the Andersen model of health behaviour (predisposing,
need and enabling). For example ‘accessibility of the test’,
‘information’ and ‘costs’ were related to the core category
‘enabling’ (Fig. 3b). Thereafter, all previously analysed
transcripts were reviewed to check that their content was
consistent with this concept (thematic analysis).
Results
In general, the focus groups were lively and participants
appeared to be open about their arguments and were
motivated to participate. All participants were able to
formulate arguments and the group interaction contrib-
uted to deepen the discussions. The groups intending to
accept gave more lively discussions, undoubtedly due to
their varied opinions, whereas the decline groups had a
higher degree of agreement between participants. Partici-
pants were relatively highly educated and the majority
had a paid job. The mean maternal age of women who
declined was 30 and of those who accepted 32. The
majority of participants were Caucasian and were not ac-
tively religious. Women declining were more often
against abortion (32 %), than those accepting (8 %). Par-
ticipants’ characteristics are summarised in Table 1.
Relative importance of factors of influence
When focus group transcripts were studied at the level of
most frequently mentioned factors, the main categories
were consequences, attitudes towards Down syndrome,
need for testing, risk perception, costs, and accessibility of
the test. Subsequently, these categories were compared
between women accepting and declining DSS.
Fig. 3 a Andersen category predisposing. Most frequently mentioned factors (more than eight times, or in at least four focus groups) were
categorised as subcategories, of which main categories were established, identified as Andersen predisposing category. b Andersen category
enabling. Most frequently mentioned factors (more than eight times, or in at least four focus groups) were categorised as subcategories, of which
main categories were established, identified as Andersen enabling category. c Andersen category need. Most frequently mentioned factors (more
than eight times, or in at least four focus groups) were categorised as subcategories, of which main categories were established, identified as
Andersen need category
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Differences in factors mentioned between women
accepting and declining DSS
Frequently mentioned arguments by women declining DSS
Women declining DSS did not consider DS a severe
enough condition to justify TOP.
“…we have decided not to participate as we decided to
keep the baby, regardless of the test result…” (F502,
post-decline group)
“So, yes, I would never consider an abortion, as this is
my child. And I would try my very best to give it every
possible opportunity for a good life” (F404, post-decline
group)
They declined the test as they wanted to prevent
potential anxiety arising from possible false positive
results.
“I don’t think I could make decisions on this (Down
syndrome), so that’s why I prefer not to be informed, to
avoid unnecessary stress” (F404, post-decline group)
Additionally, as the test result is presented as risk esti-
mation, the test would not provide full reassurance.
“….I have the impression people look for reassurance
which cannot be given, during pregnancy there are so
many things that might go wrong (so certainty is
impossible)” (F401, post-decline group)
Costs of testing were, for most women, not a reason
to decline, but the additional fee was perceived as extra
confirmation that testing was not necessary. There was
general agreement that additional costs might result in
unequal accessibility.
“Costs attached to the test do not play a role, as they
are not very high. But umm…for me it confirms I do not
belong to the high-risk group“(F202, post-decline group)
Women declining did not believe they were at high
risk of carrying a baby with DS; for some, advanced ma-
ternal age was not a reason to accept, whereas some
young women declined the test because they considered
themselves not to be at high risk for DS.
“I feel young and according to the statistics I am not
at high risk… (F904, pre-decline group)”
Frequently mentioned arguments by women accepting DSS
These women wanted to be reassured or to be prepared
to care for a child with DS, in the case of diagnosed DS.
“But if the condition is present, we want to know that
in advance” (F305, post-accept group)
An advanced maternal age was a reason to test,
whereas younger women wanted to be reassured with a
low-risk test result.
“I am already 34, people say the older you get, the
more chance that complications will arise, I do not
want invasive testing due to the risks involved,
combined testing is therefore a good option”
(F1003, pre-accept group)
“There are so many questions… you just want to be
reassured…” (F706, pre-accept group, age 26)
Women accepting the test also weighed up the impact
a child with DS could have on their family, but uncer-
tainty about expression and severity of DS made the de-
cision more complicated.
“…a child with Down syndrome…it depends…there are
severe and mild forms of it. To be honest… I haven’t
decided what to do in the case of a positive test
result…” (F104, post-accept group)
Costs were not a problem for women accepting, but
this factor discouraged others from taking the test. They
all agreed that additional costs caused inequality on a
social level.
Ambivalence
Strikingly, the majority of women accepting the test offer
showed uncertainty regarding the consequences of a
screen positive result.
“…there is no harm in taking the test, but I am not
sure what I’d do with a positive test result…” (F707,
pre-accept group).
“…supposing we have a positive test result…we haven’t
thought about that yet” (F301, post-accept group)
TOP in the case of diagnosed DS was not self-evident
and for some women diagnostic procedures were un-
acceptable due to their iatrogenic risk of pregnancy loss.
We were able to identify two groups of women within
the accept group: the majority of women were cate-
gorised as ‘ambivalent’, since they were of the opinion
that TOP in the case of diagnosed DS was not self-
evident. A smaller group of women were categorised as
‘evident’, as they were not willing to accept a child with
DS and would seriously consider TOP in the case of a
diagnosed DS foetus (Table 2).
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Table 1 Population characteristics
Variable Acceptors Decliners
Pre-counselling Post-counselling Total Pre-counselling Post-counselling Total
n n n n n n
Total number of women 10 14 24 10 12 22
Maternal age
Mean maternal age 31 33 32 31 29 30
Maternal age <36 10 12 22 10 12 22
Maternal age ≥36 2 2
Highest education
Low (secondary school) 1 1
Medium (secondary school and vocational education) 4 4 2 3 5
High (high vocational education or university) 5 14 19 8 9 17
Occupation
Paid job 7 12 19 10 11 21
Unemployed 2 1 3
Disabled
Housewife 1 1 1 1
Student 1 1
Marital status
Married 6 10 16 7 7 14
Civil partnership 3 4 7 3 5 8
Other (divorced, widowed) 1 1
Parity
Nulliparous 5 5 10 3 5 8
Multiparous 5 9 14 7 7 14
Spontaneous abortion 4 5 9 2 6 8
Religion
Active religion 1 1 2 2
No active religion 9 14 23 10 10 20
Experience with Down syndrome
Yes 4 1 5 3 5 8
No 6 13 19 7 7 14
Attitude towards abortion
In general
Against 1 1 2 2 5 7
In favour 5 12 17 6 5 11
No opinion 4 1 5 2 2 4
Personal
Yes 2 2
No 2 1 3 6 3 9
Depending on situation 8 11 19 4 9 13
Ethnicity
Western 9 14 23 10 10 20
Non-Western 1 1 2 2
Crombag et al. BMC Pregnancy and Childbirth  (2016) 16:121 Page 7 of 12
Differences in factors mentioned between pre-counselling
and post-counselling groups
To determine the possible influence that the information
provided by obstetric caregivers had over the final
choices of the participants, we compared pre- and post-
counselling groups. Both groups were formed from the
groups of women intending to accept and intending to
decline (Fig. 2).
Pre-counselling versus post-counselling focus groups of
women intending to decline
Pre-counselling, women intending to decline had mainly
found their information through the information leaflet
they received before their first visit, the internet, and an
earlier pregnancy. Post-counselling, these women more
often referred to information from tables with age-
related risks mentioned in the information leaflets. They
often recalled perceived support for their decision by
their midwife, due to a low a priori risk (Table 3).
Pre-counselling versus post-counselling focus groups of
women intending to accept
Pre-counselling, these women expressed a more positive
attitude towards DS, while women post-counselling
more often considered diagnostic testing and TOP in
the case of a confirmed DS. Information during counsel-
ling was considered concise, but despite this conciseness,
attention was given to the pros and cons of participation
and most women recalled questions such as ‘what to do
in the case of a screen positive result’. Women pre-
counselling found information on the internet or
through family/friends; post-counselling, they mainly
recalled information from their midwife or information
leaflet. Risk interpretation was only discussed in the
post-counselling groups and interpretation of the num-
bers was considered complicated and confusing. Women
in both groups referred to their age-related risk in ge-
neral, it was only in the post-counselling groups that
older women recalled their age-related risk as a factor
mentioned by their healthcare provider or that they had
read it in the information leaflet. Women perceived this
as a recommendation to participate in DSS and it made
them a little anxious (Table 3).
Pre-counselling versus post-counselling focus groups:
counsellor effect
Women declining referred to perceived support in
decision-making by their healthcare professional due to
their low a priori risk (Table 3). They recalled verbal
confirmation of their young age, healthy lifestyle and
good ultrasound results, which was interpreted as an
affirmation of their reasoning.
“And when I said no, she (the midwife) said: well…I
think since you are so young…your chances of having
an affected child are low. In this way she gave me
confirmation that I had made the right choice…and I
am happy with that, especially if a professional says it
(F402, post-decline)”
Women accepting more often expressed strong argu-
ments with regard to the consequences of the test in the
case of a screen positive result. They were asked if they
had considered possible consequences of a screen posi-
tive result. In this way, obstetric caregivers tried to
support them in analysing the pros and cons of
participation. Most women thought this was helpful,
but some felt they had to defend their decision and did
not feel supported.
“And then she (the midwife) said, but if you decide to
participate, you have to think of what…well…if it is
not a reassuring test result…what will your decision be
then (F104, post-accept)”
Table 2 Quotes related to factors mentioned by women





“I was looking for certainty, to hear that
everything was OK, and I made use of every
opportunity to have this certainty, so yes…that
also influenced my decision (F301 Post-accept)”
Preparation “But I think, it is good to be prepared when
expecting a child with Down syndrome, as far
as possible…. (F702 Pre-accept)”
Guidance “she (the midwife) gave me the information leaflet
and advised me to read it, as if she expected me
to participate… as if she hoped or wanted me to
do it… (F104 post-accept)”
Age “For me this (my age) does not play a role,
although I find it a reassuring thought that I am
still young and am not at risk regarding this





“For me, having a choice just feels good
(F102 post-accept)”
“We(me and my partner) choose to have kids,
given that we want to bring up independent
human beings […] now I can make this choice,
when a baby is born there is no choice
(F101 post-accept)”
Age “… in all these information leaflets you see
36 years of age. And when you start heading
towards 40, it really gets dramatic…and I am not
far from 40 so… well… yes… (F601 post-accept)”
“well, I am 40, so we are thinking about… yes…
what the risks are, and I think the risks increase
the older you get (F306 post-accept)”
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Pre-counselling Post-counselling Pre-counselling Post-counselling
Predisposing Attitude “for me, Down syndrome
is the least severe of all
possible disabilities, as far
as you should call it a
disability, a child could
have (F702 pre-accept)”
“if a child is still young, whether
it has Down syndrome or any
other child with special needs,
it is relatively easy to take care
of, but if they get older […]
and yes… then there is an
adult that is unable to live
independently (F104 post-accept)”“such a child can provide
so much love and can
enjoy life in his or her
own special way. That is




“if we accept the birth of a child
with Down syndrome, it means
that our oldest child will get the
responsibility after we have died.
Now, we have this opportunity to
make a choice and prevent my
daughter from being a future
family care giver
(F302 post-accept)”
Predisposing Consequences “…in the case of a screen
positive result, I haven’t
decided what to do yet.
First, the test, and then




“in the case of a screen positive





“if you participate in a test you
need to be aware of the possible
consequences […] yes, we have
talked about that extensively. We
have decided if the test result is
not good we will decide to have





from a couple that had
been pregnant before
(F701 pre-accept)
“the midwife asked me if I
wanted information on DSS.
Then I replied that I already had
all the information and wanted
the test. So that is it…
(F602 post-accept)”
“And she (the midwife) gave me
that bit of extra confirmation
by saying “I would not do it, if
I were you” If she had said the
contrary I would certainly
have reconsidered my decision
again…yes” (F405 post-decline)”
“first I searched for
information on the web,
and I also spoke to a
friend that recently did
the test
(F1003 pre-accept)”
“And then she (the midwife) said,
actually she influenced us a bit:
“it all looks good and besides
the test could also cause a lot of
extra stress (F401 post-decline)”
Need Risk
perception
“the midwife said: ‘you are 35,
you could take the combined
test’. So we said yes… why not?
If it is possible?
(F104 post-accept)”
“I am 30 years of age,
and I am young, so
therefore not at increased
risk for Down syndrome.
And besides I do
not need to know
everything in advance
(F902 pre-decline)”
“I filled in the intake-
questionnaire, that is when the
midwife said: ‘normally I do not
see such a healthy list’. I don’t
smoke, drink. But I am 30 […]
first signs were reassuring, the
scan looked good
(F401 post-decline)”
“in the Netherlands women are
strongly advised to have children
at an early age, not only for
Down syndrome, but for your
fertility as well….yes… it is
strongly advised… not sure by
whom… but it is, maybe your
doctor or the media
(F301post-accept)”
“for me the decisive reason
to decline is my young
age and I do not have
the feeling I am at risk
(F904 pre-decline)”
“… I have studied the
statistics…because I was
curious to learn about
my personal risk
(F204 post-decline)”
“one of the influencing
factors is age, so yes… I
do not expect to have an
increased risk […]so that
is why testing would
not add anything
(F803 pre-decline)
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Discussion and conclusion
Discussion
Our data showed that women in this study incorporate
different factors when making their decision. Besides in-
dividual considerations, women incorporated screening
policy characteristics into their decision. For example,
older women experienced being encouraged to use DSS,
while younger women being experienced to be discou-
raged to make use of the screening offer. These findings,
together with the finding that a diagnosed DS was not
seen as an obvious reason to terminate their pregnancy,
possibly account for the low Dutch uptake rates.
Women value their age (predisposing) by what is
generally known (external environment) and translate
this into their personal age-related risk (perceived
need) [7, 13, 18, 19]. As demonstrated in this study,
age-related risk played a major role in the decision
making process, also reflected in the strong corre-
lation between DSS uptake and age in the Netherlands
[20, 21]. This association derives from the connection
between advanced maternal age and DS [22, 23]. How-
ever, the risk assessment of foetal Down syndrome
based on maternal age alone is considerably less
accurate than determining an individual risk based on
first trimester combined testing [24]. But, as shown in
this study, women based the severity of their risk
mainly on their age and felt supported by the system
in their considerations. For example, by the informa-
tion on age-related risk in the leaflet and the informa-
tion received from their healthcare professional.
Specific characteristics of the Dutch screening
programme, such as the age-related risk and reimburse-
ment policy, appear to have framed the offer, confirming
women in their considerations regarding age-related
risk. In particular, being discouraged to participate and
the perceived need to defend their decision (enabling)
were recalled by young women accepting and might be
a reflection of this. In contrast, perceived confirmation
of their low risk by screening characteristics (enabling)
endorsed the implicit preferred choice towards non-
participation for young women.
To understand the context of the current screening
programme, some reflection is needed on the period
prior to the implementation of the programme. From
1991 until 2004, an extensive public debate took place
between government, professional groups, patient orga-
nisations and the Health Council (the main advisory or-
ganisation to the Ministry of Health in the Netherlands).
Some arguments put forward in the discussion against
screening were: fear of ‘genetic cleansing’ via the pro-
motion of termination to prevent the birth of disabled
children, and fear of an increased medicalisation of
pregnancy creating ‘unnecessary anxiety’ in pregnant
women [25–28]. Due to of these arguments, the
government had to develop a screening policy in which
equal access was guaranteed, while preventing pregnant
women from routine testing. By offering the service to
everyone, equal access was guaranteed but, contrarily, a
restraint policy was implemented by integrating ‘the
right not to know’ and an additional fee for younger
women. The screening programme, as it is now, is
unique to Europe [6, 8] and in line with the system in
which pregnancy and delivery are considered as normal
physiological processes.
Although earlier studies have demonstrated that ob-
stetric caregivers’ attitudes are of no influence on future
parents’ choices [10, 29], our data made it clear that they
acted consistently with the system’s frame of age-related
risk. Young women declining recalled support by their
healthcare professional for their decision, whereas young
women accepting recalled support in balancing ethics
(enabling). Since the majority of Dutch pregnant women
start their pregnancy with a midwife, it would be useful
to take a closer look at the strategies used to integrate
medical screening information in their consultations (see
for instance Martin et al. [30]). As described by Rosman
[31], obstetric caregivers, in this study midwives, appear
to switch from ‘alarming’ biomedical messages to ‘re-
assuring words’ to manage the anxiety induced by their
instructions and to keep control over their low medica-
lised consultation. Reflecting on a woman’s young age
and their a priori low risk for foetal anomalies indicated
the use of reassuring words. Remarkably, this only ap-
plied to women of a younger age. Perceived recommen-
dation to participate in DSS for older women in this
study is in line with the findings of Rosman. In that
study it was demonstrated that midwives ‘insisted’ on a
woman’s increased risk of having a DS baby and their
possibilities of diagnostic testing [31].
The inability to set up ‘in doubt’ groups could indicate
that most women decided on utilisation before counsel-
ling [29, 32]. But the expression of ambivalent feelings
towards subsequent consequences, in the case of a test
positive result (e.g. invasive diagnostic testing, TOP)
might reflect residual feelings of doubt. For some
women, attitudes towards DS might not be seen as rele-
vant at this stage of testing [33], reflected in the “need to
be reassured” or “prepared” as important reasons to
accept the test offer. Although it is recommended that
women make well-informed autonomous choices, fee-
lings of doubt have also been described in earlier studies
[34, 35]. Such feelings could undermine the making of
informed autonomous choices [35], but there have also
been suggestions that ambivalence contributes to weigh-
ing pros and cons more thoroughly [36]. Incorporating
uncertainties about expression and severity of DS in the
decision and considering the impact of a child with DS
on their family indicated that, in our study, ambivalence
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could be seen as a supporting factor in balancing social
and emotional dilemmas. The design of the Dutch
screening programme is probably supportive in these
considerations.
Due to the nature of this type of research, the par-
ticipants generally had a higher degree of education,
often originated from Western countries, spoke Dutch
and were on average somewhat older which may limit
the findings of our study. Additionally, the number of
religious women in this study was low, while research
has demonstrated that religious conviction plays an
important role in decision-making [13, 20]. To create
a safe environment, we organised focus groups with
women only and groups had a homogenous set up
[15, 16]. Information on the role partners played in
the decision-making process was based on the preg-
nant women’s perceptions, which might be different
from their partners’ opinions. Homogenous groups
were set up to create a safe environment, which is an
advantage of this approach, but might have under-
mined the discussion on contrasting arguments. The
inability to form ‘in doubt’ focus groups may have re-
stricted the discussion on the subject of doubt, but
the finding of ambivalence and further investigation
gave a more profound impression of the deliberations
in the decision-making, characterised by feelings of
hesitance.
Conclusions
In conclusion, different factors are influential in the DSS
process. Women incorporate individual factors and are
aware of ethical implications. However, for some, choices
are partially determined by the system in which they are
offered. Women base the severity of their risk on their
age and feel that their considerations are sustained by
the system.
Future research should further focus on generalisabi-
lity of these findings. Therefore, the effect of system cha-
racteristics on individual decision-making should be
tested in large representative groups of women. The
conflicting restrictions of the programme seem to
encourage young women not to participate, which is in-
consistent with the principle of autonomous decision-
making. In January 2015 the Dutch reimbursement po-
licy on prenatal screening changed. A fee now has to be
paid for the combined test by all pregnant women
(regardless of age) as a means to treat all pregnant
women alike. The effect on accessibility remains unclear
given the restrictive effect due to this new financial
threshold for older pregnant women. Policy makers
should be aware of these (unintended) side effects, and
screening programmes aimed at informed and autono-
mous decision-making should ideally be offered without
conflicting restrictions.
Decision-making in Down syndrome screening should
be based on the personal interest in knowing the in-
dividual risk of having a child with Down syndrome and
participation should not be influenced by system
characteristics. To support women in informed and
autonomous decision-making, policy makers and ob-
stetric caregivers should therefore: obstetric caregivers
1) inform all women that every person has their own
individual risk on having a child with DS, despite their
age; and 2) discuss consequences of both accepting and
declining testing with all women, regardless of their
decision. Only then can obstetric caregivers support
women in making the right considerations on accepting
or declining DSS. This not only applies to DSS based
on classic first trimester biochemical screening in ma-
ternal serum, but also to emerging alternative methods
such as non-invasive testing based on cell-free foetal
DNA in maternal blood. As the consequences of testing
could comprise ethical dilemmas, informed and au-
tonomous decision-making is essential and impartial
information about the consequences of both accepting




DS: Down syndrome; DSS: Down syndrome screening; TOP: Termination of
pregnancy.
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